Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Estimating the burden of SARS-CoV-2 in France

Open access

Published version of a preprint

Abstract

COVID-19 pandemic in France: Coronavirus disease 2019 (COVID-19) exacted a heavy toll in France during March and April 2020. Quarantine measures were effective in reducing transmission by 84%, and some relaxation of social isolation was expected in May. Salje et al. fit transmission models for the epidemic in France to hospital admissions. The authors forecast that 2.9 million people will have been infected by 11 May, representing 4.4% of the population—a value inadequate for herd immunity. Daily critical care hospitalizations should reduce from several hundreds to tens of cases, but control will remain a delicate balancing act. Any relaxation of lockdown in France will have to be carefully controlled and monitored to avoid undermining more optimistic forecasts. Science , this issue p. 208

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.abc3517

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 COVID-19 hospitalizations and deaths in France. (A) Cumulative number of general ward and ICU hospitalizations, ICU admissions, and deaths from COVID-19 in France. The vertical green line indicates the time when the lockdown was put in place in France. (B) Geographical distribution of deaths in France. Number of (C) hospitalizations, (D) ICU admissions, and (E) deaths by age group and sex in France.
Fig. 1 COVID-19 hospitalizations and deaths in France. (A) Cumulative number of general ward and ICU hospitalizations, ICU admissions, and deaths from COVID-19 in France. The vertical green line indicates the time when the lockdown was put in place in France. (B) Geographical distribution of deaths in France. Number of (C) hospitalizations, (D) ICU admissions, and (E) deaths by age group and sex in France.CC BY · PubMed Central
Fig. 2 Probabilities of hospitalization, ICU admission, and death. (A) Probability of hospitalization among those infected as a function of age and sex. (B) Probability of ICU admission among those hospitalized as a function of age and sex. (C) Probability of death among those hospitalized as a function of age and sex. (D) Probability of death among those infected as a function of age and sex. For each panel, the horizontal black line and gray shaded region represent the overall mean across all ages. The boxplots represent the 2.5, 25, 50, 75, and 97.5 percentiles of the posterior distributions.
Fig. 2 Probabilities of hospitalization, ICU admission, and death. (A) Probability of hospitalization among those infected as a function of age and sex. (B) Probability of ICU admission among those hospitalized as a function of age and sex. (C) Probability of death among those hospitalized as a function of age and sex. (D) Probability of death among those infected as a function of age and sex. For each panel, the horizontal black line and gray shaded region represent the overall mean across all ages. The boxplots represent the 2.5, 25, 50, 75, and 97.5 percentiles of the posterior distributions.CC BY · PubMed Central
Fig. 3 Time course of the SARS-CoV-2 pandemic to 11 May 2020. (A) Daily ICU admissions in metropolitan France. (B) Number of ICU beds occupied in metropolitan France. (C) Daily hospital admissions in metropolitan France. (D) Number of general ward beds (in thousands) occupied in metropolitan France. (E) Daily new infections in metropolitan France (logarithmic scale). (F) Predicted proportion of the population infected by 11 May 2020 for each of the 13 regions in metropolitan France. (G) Predicted proportion of the population infected in metropolitan France. The solid circles in (A) to (D) represent hospitalization data used for the calibration, and the open circles represent hospitalization data that were not used for calibration. The dark-blue shaded areas correspond to 50% credible intervals, and the light-blue shaded areas correspond to 95% credible intervals. The dashed lines in (E) and (G) represent the 95% uncertainty range stemming from the uncertainty in the probability of hospitalization after infection.
Fig. 3 Time course of the SARS-CoV-2 pandemic to 11 May 2020. (A) Daily ICU admissions in metropolitan France. (B) Number of ICU beds occupied in metropolitan France. (C) Daily hospital admissions in metropolitan France. (D) Number of general ward beds (in thousands) occupied in metropolitan France. (E) Daily new infections in metropolitan France (logarithmic scale). (F) Predicted proportion of the population infected by 11 May 2020 for each of the 13 regions in metropolitan France. (G) Predicted proportion of the population infected in metropolitan France. The solid circles in (A) to (D) represent hospitalization data used for the calibration, and the open circles represent hospitalization data that were not used for calibration. The dark-blue shaded areas correspond to 50% credible intervals, and the light-blue shaded areas correspond to 95% credible intervals. The dashed lines in (E) and (G) represent the 95% uncertainty range stemming from the uncertainty in the probability of hospitalization after infection.CC BY · PubMed Central
Fig. 4 Sensitivity analyses considering different modeling assumptions. (A) Infection fatality rate (%). (B) Estimated reproduction numbers before (R0) and during lockdown (Rlockdown). (C) Predicted daily new infections on 11 May. (D) Predicted proportion of the population infected by 11 May. The different scenarios are as follows: “Children less inf,” individuals under 20 years of age are half as infectious as adults; “No Change CM,” the structure of the contact matrix (CM) is not modified by the lockdown; “CM SDE,” contact matrix after lockdown with very high social distancing of the elderly; “Constant AR,” attack rates are constant across age groups; “Higher IFR,” French people are 25% more likely to die than Diamond Princess passengers; “Higher AR DP,” 25% of the infections were undetected on the Diamond Princess cruise ship; “Delay Distrib,”single hospitalization to death delay distribution; “Higher delay to hosp,” 8 days on average between symptom onset and hospitalization for patients who will require ICU admission and 9 days on average between symptom onset and hospitalization for the patients who will not; “14 Deaths DP,” the final passenger of the Diamond Princess in ICU survives. For estimates of IFR and reproduction numbers before and during lockdown, we report 95% credible intervals. For estimates of daily new infections and proportion of the population infected by 11 May, we report the 95% uncertainty range stemming from the uncertainty in the probability of hospitalization given infection.
Fig. 4 Sensitivity analyses considering different modeling assumptions. (A) Infection fatality rate (%). (B) Estimated reproduction numbers before (R0) and during lockdown (Rlockdown). (C) Predicted daily new infections on 11 May. (D) Predicted proportion of the population infected by 11 May. The different scenarios are as follows: “Children less inf,” individuals under 20 years of age are half as infectious as adults; “No Change CM,” the structure of the contact matrix (CM) is not modified by the lockdown; “CM SDE,” contact matrix after lockdown with very high social distancing of the elderly; “Constant AR,” attack rates are constant across age groups; “Higher IFR,” French people are 25% more likely to die than Diamond Princess passengers; “Higher AR DP,” 25% of the infections were undetected on the Diamond Princess cruise ship; “Delay Distrib,”single hospitalization to death delay distribution; “Higher delay to hosp,” 8 days on average between symptom onset and hospitalization for patients who will require ICU admission and 9 days on average between symptom onset and hospitalization for the patients who will not; “14 Deaths DP,” the final passenger of the Diamond Princess in ICU survives. For estimates of IFR and reproduction numbers before and during lockdown, we report 95% credible intervals. For estimates of daily new infections and proportion of the population infected by 11 May, we report the 95% uncertainty range stemming from the uncertainty in the probability of hospitalization given infection.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

Items 701–800 of 1,001

Metadata

Authors
Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., Le Strat, Y., Lessler, J., Levy-Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P.-Y., & Cauchemez, S.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
  • Ministère des Solidarités et de la Santé (FR)
  • Santé Publique France, French National Public Health Agency, Saint-Maurice, France.
  • Johns Hopkins University (US)
  • Conservatoire National des Arts et Métiers (FR)
  • Inserm (FR)
  • Institut Pierre Louis d’Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.
Corresponding author
Cauchemez, Simon
Venue
Science
Published
2020-07-10
Volume
369
Issue
6500
Pages
208-211
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3025090814
Cited by
1,038
References
30
Citations by year
2026: 15 · 2025: 29 · 2024: 50 · 2023: 90 · 2022: 171 · 2021: 378 · 2020: 303
FWCI
37.42
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc-nd)
  • HAL (submittedVersion, cc-by-nc)
Funders
  • H2020 European Research Council (804744)
  • ANR (ANR-10-LABX-62-IBEID)
  • INCEPTION (PIA/ANR-16-CONV-0005)
  • Santé Publique France
  • European Union RECOVER
  • University of Cambridge COVID-19 Rapid Response Grant
Topics
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, hospitalization rates, mortality rates, lockdown, reproduction number, herd immunity, age and sex differences, intensive care, second wave, France
MeSH terms
COVID-19, Adolescent, Adult, Aged, Aged, 80 and over, Critical Care, Female, France, Hospitalization, Humans, Immunity, Male, Middle Aged, Pneumonia, Viral, Quarantine, Cost of Illness, Coronavirus Infections, Severe acute respiratory syndrome-related coronavirus, Young Adult, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.